We need a million grids a year, but they are currently made by hand with tweezers. The LMB is about to change that for good.
The round was led by Sofinnova Partners and Redmile Group.
The MRC LMB and AstraZeneca in Cambridge collaborated on work that could explain why cardiac events are more common in the elderly in the morning.
The Babraham Research Campus biopharma will receive upfront fees of $17.5m.
The novel biological target identified using AI has been experimentally validated.
They are working alongide industry experts on real-time projects.
It is working with Daiichi Sankyo on Enhertu.
VaxEquity could receive up to $195m.
The company recently secured £890,000 from Cambridge-based CMS Ventures.
They used federated learning to train an algorithm without sharing data.
It intends to expand in the US in 2022.
Two new investors have joined.
It had been heading for the courts.
Milton-based CCL has teamed up with Prostatype Genomics.
The novel tests could be used to inform vaccination practice.
Two targets have been identified.
Industry veterans have backed the company.